StockData
CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc. (CTMX) bonds

CTMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$1.88−0.06 (-3.09%)

Close on Nov 18, 2026Market cap $409.65MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

CytomX Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in CytomX Therapeutics's 10-K for the period ended May 31, 2012

CytomX Therapeutics's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Master Loan and Security Agreement$2.00M

See a number that looks wrong?